-
EP2298284
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2298284
| EP2298284 - Mucoadhesive pharmaceutical formulations [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 29.09.2017 Database last updated on 24.01.2025 | |
| Former | Examination is in progress Status updated on 11.11.2016 | Most recent event Tooltip | 29.09.2017 | Application deemed to be withdrawn | published on 01.11.2017 [2017/44] | Applicant(s) | For all designated states GW Pharma Limited Sovereign House Histon Cambridge CB24 9BZ / GB | [2015/18] |
| Former [2011/12] | For all designated states GW Pharma Limited Porton Down Science Park Salisbury Wiltshire SP4 0JR / GB | Inventor(s) | 01 /
Whittle, Brian Wortley House 16 Eastbourne Road Hornsea, Yorkshire HU18 1QS / GB | 02 /
Guy, Geoffrey South House Piddletrenthide Dorchester, Dorset DT2 7QP / GB | [2011/12] | Representative(s) | HGF 4th Floor Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | [N/P] |
| Former [2014/07] | Wells, Andrew, et al Harrison Goddard Foote LLP 4th Floor, Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | ||
| Former [2011/12] | Harrison Goddard Foote 4th Floor Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | Application number, filing date | 10180665.1 | 14.02.2002 | [2011/12] | Priority number, date | GB20010003638 | 14.02.2001 Original published format: GB 0103638 | US20010280044P | 30.03.2001 Original published format: US 280044 P | US20010827158 | 05.04.2001 Original published format: US 827158 | GB20010011597 | 11.05.2001 Original published format: GB 0111597 | GB20010021715 | 07.09.2001 Original published format: GB 0121715 | US20010951022 | 12.09.2001 Original published format: US 951022 | [2011/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2298284 | Date: | 23.03.2011 | Language: | EN | [2011/12] | Type: | A3 Search report | No.: | EP2298284 | Date: | 18.12.2013 | Language: | EN | [2013/51] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.11.2013 | Classification | IPC: | A61K9/127, A61K9/00, A61K31/352 | [2011/12] | CPC: |
A61K9/006 (EP);
A61K9/00 (KR);
A61K9/0031 (EP);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/14 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/06 (EP);
A61P25/08 (EP);
A61P29/00 (EP);
A61P3/04 (EP);
A61P37/00 (EP);
A61P39/00 (EP);
A61P39/06 (EP);
A61P9/00 (EP);
A61K9/0056 (EP);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2011/12] | Extension states | RO | Not yet paid | SI | Not yet paid | Title | German: | Mucoadhäsive pharmazeutische Formulierungen | [2011/12] | English: | Mucoadhesive pharmaceutical formulations | [2011/12] | French: | Formulations pharmaceutiques mucoadhésives | [2011/12] | Examination procedure | 17.06.2014 | Amendment by applicant (claims and/or description) | 17.06.2014 | Examination requested [2014/31] | 15.11.2016 | Despatch of a communication from the examining division (Time limit: M06) | 27.05.2017 | Application deemed to be withdrawn, date of legal effect [2017/44] | 22.06.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/44] | Parent application(s) Tooltip | EP02712063.3 / EP1361864 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20020712063) is 11.07.2006 | Fees paid | Renewal fee | 28.09.2010 | Renewal fee patent year 03 | 28.09.2010 | Renewal fee patent year 04 | 28.09.2010 | Renewal fee patent year 05 | 28.09.2010 | Renewal fee patent year 06 | 28.09.2010 | Renewal fee patent year 07 | 28.09.2010 | Renewal fee patent year 08 | 28.09.2010 | Renewal fee patent year 09 | 07.12.2010 | Renewal fee patent year 10 | 01.12.2011 | Renewal fee patent year 11 | 04.12.2012 | Renewal fee patent year 12 | 05.12.2013 | Renewal fee patent year 13 | 29.12.2014 | Renewal fee patent year 14 | 27.01.2016 | Renewal fee patent year 15 | 13.01.2017 | Renewal fee patent year 16 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9525504 (PHARMAVENE INC [US], et al) [X] 1-10,13,16-18 * page 1, paragraph f - paragraph l * * page 12, paragraph 3 - page 14, paragraph 1 * * claims 1,5,6,15, *; | [X]US5891469 (AMSELEM SHIMON [IL]) [X] 1-10,13,16-18 * column 1, line 20 - line 58 * * column 3, line 60 - line 65 * * column 4, line 50 - line 54 * * column 6, line 16 - line 22 * * claims 1,14 *; | [I]WO9953917 (US HEALTH [US], et al) [I] 14,15* figures 3,4; examples 5,6 *; | [Y]WO9956727 (ELAN CORP PLC [IE], et al) [Y] 1-10,13,16-18 * page 5, line 26 - page 6, line 14 * * page 7, line 4 - line 20 * * page 11, line 22 - page 12, line 19 * * page 14, line 9 - line 16 *; | [X]WO0050007 (LIPOCINE INC [US]) [X] 1-10,13,16-18 * page 4, line 16 - line 22 * * page 5, line 1 - page 3 * * page 5, line 18 - line 33 * * page 33, line 11 * * page 36, line 27 * * page 38, line 24 - page 39, line 10 * * page 41, line 14 - line 23 * * claims 1,45-47,64-68 *; | [E]WO0232420 (DELTA 9 PHARMA GMBH [DE], et al) [E] 11,12 * tables 1,3 *; | [E]WO02069993 (FORSCH HISCIA VER FUER KREBSFO [CH], et al) [E] 11,12 * page 2, line 20 - page 3, line 2 * * page 6, line 23 - line 35 * * example 2 *; | [Y] - POUTON C W, "FORMULATION OF SELF-EMULSIFYING DRUG DELIVERY SYSTEMS", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL, (19970414), vol. 25, no. 1, doi:10.1016/S0169-409X(96)00490-5, ISSN 0169-409X, pages 47 - 58, XP000866526 [Y] 1-10,13,16-18 * the whole document * DOI: http://dx.doi.org/10.1016/S0169-409X(96)00490-5 | [Y] - SERAJUDDIN A T M, "BIOAVAILABILITY ENHANCEMENT OF POORLY WATER-SOLUBLE DRUGS BY SOLID DISPERSION IN SURFACE ACTIVE AND SELF-EMULSIFYING VEHICLES", BULLETIN TECHNIQUE GATTEFOSSE REPORT, GATTEFOSSE, SAINT-PRIEST, FR, (19970101), vol. 90, ISSN 1149-0306, pages 43 - 50, XP001012675 [Y] 1-10,13,16-18 * the whole document * | [A] - KARNIOL I G ET AL, "Cannabidiol interferes with the effects of DELTA<9>-tetrahydrocannabinol in man", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER SCIENCE, NL, vol. 28, no. 1, doi:10.1016/0014-2999(74)90129-0, ISSN 0014-2999, (19740901), pages 172 - 177, (19740901), XP025511201 [A] 11,12 * the whole document * DOI: http://dx.doi.org/10.1016/0014-2999(74)90129-0 | [A] - LEO E. HOLLISTER ET AL, "Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol", CLINICAL PHARMACOLOGY AND THERAPEUTICS, (19750101), vol. 18, no. 1, pages 80 - 83, XP055087927 [A] 11,12 * the whole document * DOI: http://dx.doi.org/10.1002/cpt197518180 | [A] - A. W. ZUARDI ET AL, "Action of cannabidiol on the anxiety and other effects produced by delta-9-THC in normal subjects", PSYCHOPHARMACOLOGY, (19820101), vol. 76, pages 245 - 250, XP055087931 [A] 11,12 * the whole document * | [I] - EITAN ALHANATY; ET AL., "Osmotic fragility of liposomes as affected by antihemolytic compounds", BIOCHIMICA ET BIOPHYSICA ACTA, (1974), vol. 339, no. 1, pages 146 - 155, XP008008726 [I] 14,15 * page 152; figure 7 * DOI: http://dx.doi.org/10.1016/0005-2736(74)90340-X | by applicant | US5540934 | - ADAMS M.D ET AL., "A Cannabinoid with Cardiovascular Activity but no Overt Behavioural Effects", EXPERIENTIA, (1977), vol. 33, pages 1204 - 1205 | - BURSTEIN S.; RAZ A., "Inhibition of prostaglandin E2 biosynthesis by D1-tetrahydrocannabinol.", PROSTAGLANDINS, (1972), vol. 2, pages 369 - 375 | - CARLINI E.A.; LEITER J.R.; TANNHAUSER M.; BERARDI A.C., "Cannabidiol and Cannabis sativa Extract Protect Mice and Rats Against Convulsive Agents", J. PHARM. PHARMACOL, (1973), vol. 25, pages 664 - 665 | - DE MEIJER E.P.M.; KEIZER L.C.P., "Patterns of diversity in Cannabis.", GENETIC RESOURCES AND CROP EVOLUTION, (1996), vol. 43, doi:doi:10.1007/BF00126939, pages 41 - 52, XP009121796 DOI: http://dx.doi.org/10.1007/BF00126939 | - HAMPSON A.J.; GRIMALDI M.; AXELROD J.; WINK D., "Cannabidiol and (-) 9-Tetrahydrocannabinol are Neuroprotective Antioxidants", PROC. NAT. ACAD. SCI., (1998), vol. 95, pages 8268 - 8273 | - HARDY ET AL., RESPIRATORY MEDICINE, (1993), vol. 87, pages 461 - 465 | - IVERSEN L.L., The Science of Marijuana, OXFORD UNIVERSITY PRESS, (2000), pages 48 - 49 | - Merck Index, (1996), page 1792 | - Merck's Manual, (1899), page 26 | - PERTWEE R.G., Advances in Cannabinoid Receptor Pharmacology in Cannabis The Genus Cannabis, HARWOOD, (1998), pages 125 - 174 | - PETRO D.J., "Marijuana as a Therapeutic Agent for Muscle Spasm or Spasticity", PSYCHOSOMATICS, (1980), vol. 21, no. 1, pages 81 - 85 | - "Cannabis in Pain Relief In Cannabis", PRICE M A P; NOTCUTT W G, The Genus Cannabis, HARWOOD, pages 223 - 246 | - RAMAN A., The Cannabis Plant: Cultivation and Processing for Use In Cannabis: the genus Cannabis, pages 29 - 54 | - RAM; SETT, ZEITSCHRIFT FUR PFLANZENPHYSIOLOGIE, (1982), vol. 107, no. 1, pages 85 - 89 | - SAMUELSSON G, Drugs of Natural Origin, SWEDISH PHARMACEUTICAL PRESS, pages 155 - 160 | - SMILEY K.A.; KARBER R.; TURKANIS S.A., "Effect of Cannabinoids on the Perfussed Rat Heart", RES. COMM. CHEM. PATHOL. PHARMACOL, (1976), vol. 14, pages 659 - 673 | - TASHKIN D P; SHAPIRO B J; FRANK I M, N ENG J MED, vol. 289, pages 336 - 341 | - TOUITOU E; FABIN B; DANNY S; ALMOG S, "Transdermal Delivery of Tetrahydrocannabinol", INT. J. OF PHARMACEUTICS, (1988), vol. 43, doi:doi:10.1016/0378-5173(88)90052-X, pages 9 - 15, XP025544008 DOI: http://dx.doi.org/10.1016/0378-5173(88)90052-X | - "Cannabidiol as an Anxiolytic and Antipsychotic in Cannabis", ZUARDI A.W.; GUIMARES F.S., The Medicine Plant, MCFARLAND & CO, (1991), pages 133 - 141 | US19970919317 | GB20000025809 | GB20000025811 | GB20010003638 |